Literature DB >> 6801069

Prolactin responses, menstrual cycles, and body composition of women runners.

T W Boyden, R W Pamenter, D Grosso, P Stanforth, T Rotkis, J H Wilmore.   

Abstract

Fourteen young women with normal menses participated in an endurance running program to investigate the effects of physical training on menstrual function, plasma PRL, and body composition. Body composition, measured by hydrostatic weighing, and PRL (basal and TRH-stimulated ) were determined initially and after each subject had increased her weekly mileage by 30 miles (delta 30) and 50 miles (delta 50). Mean (+/- SEM) total body weight did not change, but the subjects became significantly leaner (relative fat, 25.5 +/- 1.3% at baseline vs. 22.4 +/- 0.9% at delta 50; P less than 0.02). Thirteen women developed menstrual changes (mainly oligomenorrhea), but not amenorrhea. Mean (+/- SEM) unstimulated PRL levels were 16.8 +/- 3.1%, 16.9 +/- 2.4, and 11.5 +/- 2.1 ng/ml at baseline, delta 30, and delta 50, respectively (P less than 0.03 at delta 50 compared to baseline and delta 30). Mean ( +/- SEM) integrated TRH-stimulated PRL responses increased from 5002 +/- 462 ng/ml.min at baseline to 5748 +/- 609 mg/ml.min at delta 30 and 6535 +/- 552 ng/ml.min at delta 50, and were significantly different from one another (F = 4.01; P less than 0.04). Endurance training, without total body weight loss or extreme leanness, results in frequent menstrual dysfunction. Other authors have shown that young female athletes have an increased PRL response to acute exercise compared to nonathletes. One mechanism responsible for menstrual dysfunction in endurance-trained women may be frequent and exaggerated PRL responses to exercise and other stimuli.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6801069     DOI: 10.1210/jcem-54-4-711

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  20 in total

1.  Relationship of resting prolactin and testosterone in males during intensive training.

Authors:  A C Hackney; R L Sharp; W S Runyan; R J Ness
Journal:  Br J Sports Med       Date:  1989-09       Impact factor: 13.800

Review 2.  Body composition and menstrual function in athletes.

Authors:  W E Sinning; K D Little
Journal:  Sports Med       Date:  1987 Jan-Feb       Impact factor: 11.136

3.  The thyroid axis, prolactin, and exercise in humans.

Authors:  Anthony C Hackney; Ayoub Saeidi
Journal:  Curr Opin Endocr Metab Res       Date:  2019-07-05

4.  Reproductive Dysfunction from the Stress of Exercise Training is not Gender Specific: The "Exercise-Hypogonadal Male Condition".

Authors:  Amy R Lane; Anthony C Hackney
Journal:  J Endocrinol Diabetes       Date:  2014-05-30

5.  Energy Availability Is Associated With Luteinizing Hormone Pulse Frequency and Induction of Luteal Phase Defects.

Authors:  Kristen J Koltun; Mary Jane De Souza; Jennifer L Scheid; Nancy I Williams
Journal:  J Clin Endocrinol Metab       Date:  2020-01-01       Impact factor: 5.958

6.  Reversibility of amenorrhoea in athletes.

Authors:  J M Stager
Journal:  Sports Med       Date:  1984 Sep-Oct       Impact factor: 11.136

Review 7.  Physical exercise and menstrual cycle alterations. What are the mechanisms?

Authors:  H A Keizer; A D Rogol
Journal:  Sports Med       Date:  1990-10       Impact factor: 11.136

8.  Energy balance, early life body size, and plasma prolactin levels in postmenopausal women.

Authors:  Xuefen Su; Susan E Hankinson; Charles V Clevenger; A Heather Eliassen; Shelley S Tworoger
Journal:  Cancer Causes Control       Date:  2008-10-14       Impact factor: 2.506

Review 9.  Sex steroid metabolism and menstrual irregularities in the exercising female. A review.

Authors:  C De Crée
Journal:  Sports Med       Date:  1998-06       Impact factor: 11.136

Review 10.  Effects of endurance exercise on the reproductive system of men: the "exercise-hypogonadal male condition".

Authors:  A C Hackney
Journal:  J Endocrinol Invest       Date:  2008-10       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.